Vapotherm Inc Revenue Growth Rates (VAPO), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Vapotherm Inc   (VAPO)
 

VAPO's Revenue Growth by Quarter and Year

Vapotherm Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VAPO Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter December -
3rd Quarter September -
2nd Quarter June 16.88
1st Quarter March 19.13
FY 36.01

VAPOs Annual Revenue
Vapotherm Inc 's Revenue in the fiscal year 2023 $ 68.67 millions
Vapotherm Inc 's Revenue in the fiscal year 2022 $ 66.80 millions
Vapotherm Inc 's Revenue in the fiscal year 2021 $ 113.29 millions
Vapotherm Inc 's Revenue in the fiscal year 2020 $ 125.73 millions
Vapotherm Inc 's Revenue in the fiscal year 2019 $ 48.10 millions




VAPO Revenue second quarter 2024 Y/Y Growth Comment
Vapotherm Inc reported Revenue growth of 5.26% year on year in the second quarter 2024, to $ 16.88 millions, this is lower than Vapotherm Inc 's recent average Revenue improvement of 26.95%.

Looking into second quarter 2024 results within Medical Equipment & Supplies industry 110 other companies have achieved higher Revenue growth. While Vapotherm Inc ' s Revenue increase of 5.26% ranks overall at the positon no. 1822 in the second quarter 2024.


VAPO Revenue ( Y/Y Growth %) 2024
 2023 2022 2021
4th Quarter December - 5.73 % -16.1 % -45.64 %
3rd Quarter September - 11.96 % -64.45 % 24.74 %
2nd Quarter June 5.26 % 23.67 % -37.13 % -41.31 %
1st Quarter March 7.9 % -17.99 % -33.09 % 68.99 %
FY   - 2.8 % -41.04 % -

Financial Statements
Vapotherm Inc 's second quarter 2024 Revenue $ 16.88 millions VAPO's Income Statement
Vapotherm Inc 's second quarter 2023 Revenue $ 16.04 millions Quarterly VAPO's Income Statement


VAPO Revenue (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
4th Quarter December - 30.06 % 37.71 % -41.66 %
3rd Quarter September - -5.42 % 4.47 % 84.78 %
2nd Quarter June -11.74 % -9.53 % -40.01 % -36.15 %
1st Quarter March -3.04 % -4.98 % -2.79 % -21.02 %
FY (Year on Year)   - 2.8 % -41.04 % -


Back to VAPO Growth rate Comparisons >> Back to VAPO Growth rate Comparisons >>


Revenue second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #111
Healthcare Sector #362
Overall #1822

Revenue Y/Y Growth Statistics
High Average Low
214.43 % 26.95 % -64.46 %
(Dec 31 2020)   (Sep 30 2022)
Revenue second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #111
Healthcare Sector #362
Overall #1822
Revenue Y/Y Growth Statistics
High Average Low
214.43 % 26.95 % -64.46 %
(Dec 31 2020)   (Sep 30 2022)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Vapotherm Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
84.8 % 6.68 % -41.64 %
(Sep 30 2021)  


VAPO's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2024 Vapotherm Inc disclosed drop in Revenue from the first quarter by -11.74% to $ 16.88 millions, from $ 19.13 millions achived in the previous reporting period.

But that's not important problem, as Vapotherm Inc 's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 171 other companies have achieved higher Revenue quarter on quarter growth. While Vapotherm Inc 's Revenue growth quarter on quarter, overall rank is 3465.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #172
Healthcare Sector #525
Overall #3465
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #172
Healthcare Sector #525
Overall #3465
Revenue Q/Q Growth Statistics
High Average Low
84.8 % 6.68 % -41.64 %
(Sep 30 2021)  


VAPO's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2024 Vapotherm Inc disclosed drop in Revenue from the first quarter by -11.74% to $ 16.88 millions, from $ 19.13 millions achived in the previous reporting period.

But that's not important problem, as Vapotherm Inc 's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 171 other companies have achieved higher Revenue quarter on quarter growth. While Vapotherm Inc 's Revenue growth quarter on quarter, overall rank is 3465.


Vapotherm Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Sep 30 2023)		 12 Months Ending
(Jun 30 2023)
Cumulative Revenue 12 Months Ending $ 70.92 $ 70.07 $ 68.67 $ 67.60 $ 65.98
Y / Y Revenue Growth (TTM) 7.49 % 11.38 % 2.8 % -3.96 % -30.52 %
Year on Year Revenue Growth Overall Ranking # 3343 # 0 # 0 # 3508 # 3325
Seqeuential Revenue Change (TTM) 1.21 % 2.04 % 1.58 % 2.46 % 4.87 %
Seq. Revenue Growth (TTM) Overall Ranking # 1540 # 0 # 0 # 3291 # 1808


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2024 period, Vapotherm Inc 's cumulative twelve months Revenue were $ 71 millions, company would post below average annual Revenue growth of 4.87% year on year, if the fiscal year would end at Jun 30 2024.
A slow-down in the Vapotherm Inc 's Revenue growth from the 19.13% growth in Mar 31 2024.

In the Healthcare sector 467 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 3343.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 97
Healthcare Sector # 468
Overall # 3343

Revenue TTM Y/Y Growth Statistics
High Average Low
161.38 %
 13.98 %
-46.66 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 97
Sector # 295
S&P 500 # 1540
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2024 period, Vapotherm Inc 's cumulative twelve months Revenue were $ 71 millions, company would post below average annual Revenue growth of -46.66% year on year, if the fiscal year would end at Jun 30 2024.
A slow-down in the Vapotherm Inc 's Revenue growth from the 19.13% growth in Mar 31 2024.

In the Healthcare sector 467 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 3343.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 97
Healthcare Sector # 468
Overall # 3343

Revenue TTM Y/Y Growth Statistics
High Average Low
161.38 %
13.98 %
-46.66 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 97
Sector # 295
S&P 500 # 1540




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
VAPO's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Jun 30 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2024
Ati Physical Therapy Inc 9.15%$ 9.154 millions
Electromed Inc 8.96%$ 8.963 millions
Acadia Healthcare Company Inc 8.85%$ 8.847 millions
Progyny Inc 8.84%$ 8.843 millions
Integer Holdings Corporation8.84%$ 8.836 millions
Icu Medical Inc8.77%$ 8.772 millions
Bristol myers Squibb Company8.69%$ 8.685 millions
Stryker Corp8.53%$ 8.527 millions
Strata Skin Sciences Inc8.46%$ 8.459 millions
Sotera Health Company8.33%$ 8.328 millions
Zoetis Inc 8.30%$ 8.303 millions
Ocular Therapeutix Inc 8.26%$ 8.264 millions
Keenova Therapeutics Plc8.23%$ 8.233 millions
Livanova Plc8.16%$ 8.161 millions
Steris Plc8.12%$ 8.122 millions
Envoy Medical Inc 7.94%$ 7.937 millions
Phibro Animal Health Corporation7.76%$ 7.765 millions
Chemed Corporation7.60%$ 7.595 millions
Ardent Health Inc 7.47%$ 7.466 millions
Collegium Pharmaceutical Inc 7.40%$ 7.402 millions
Teva Pharmaceutical Industries Limited7.37%$ 7.375 millions
Staar Surgical Co7.26%$ 7.257 millions
Merck and Co Inc 7.16%$ 7.163 millions
Tactile Systems Technology Inc 7.03%$ 7.034 millions
Jazz Pharmaceuticals Plc6.95%$ 6.947 millions
Amedisys Inc6.91%$ 6.912 millions
Exagen Inc 6.56%$ 6.557 millions
Maravai Lifesciences Holdings Inc 6.51%$ 6.510 millions
National Healthcare Corp6.40%$ 6.397 millions
Idexx Laboratories Inc6.31%$ 6.309 millions


About Vapotherm Inc Revenue Growth Rates (VAPO), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Vapotherm Inc (CIK 1253176).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0000950170-24-095540
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Vapotherm Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.